Seront E - Search Results

1

Future Strategies Involving Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.

Grisay G, Pierrard J, Confente C, Seront E. Grisay G, et al. Among authors: seront e. Curr Treat Options Oncol. 2020 Dec 2;22(1):7. doi: 10.1007/s11864-020-00799-9. Curr Treat Options Oncol. 2020. PMID: 33269438 Review.

2

Targeted treatment in complex lymphatic anomaly: a case of synergistic efficacy of trametinib and sirolimus.

Seront E, Froidure A, Revencu N, Dekeuleneer V, Clapuyt P, Dumitriu D, Vikkula M, Boon LM. Seront E, et al. Orphanet J Rare Dis. 2024 May 16;19(1):199. doi: 10.1186/s13023-024-03211-z. Orphanet J Rare Dis. 2024. PMID: 38750525 Free PMC article.

3

A case report of sirolimus use in early fetal management of lymphatic malformation.

Seront E, Biard JM, Van Damme A, Revencu N, Lengelé B, Schmitz S, de Toeuf C, Clapuyt P, Veyckemans F, Prégardien C, Vikkula M, Bernard P, Boon LM. Seront E, et al. Nat Cardiovasc Res. 2023 Jun;2(6):595-599. doi: 10.1038/s44161-023-00280-4. Epub 2023 Jun 1. Nat Cardiovasc Res. 2023. PMID: 39195878

4

Systemic Treatments for Metastatic Prostate Cancer in 2024.

Gizzi M, Seront E, Tombal B, Van Damme J. Gizzi M, et al. Among authors: seront e. Eur Urol Focus. 2024 Jul;10(4):522-524. doi: 10.1016/j.euf.2024.07.013. Epub 2024 Aug 10. Eur Urol Focus. 2024. PMID: 39127526

5

Targeted treatments for vascular malformations: current state of the art.

Seront E, Hermans C, Boon LM, Vikkula M. Seront E, et al. J Thromb Haemost. 2024 Nov;22(11):2961-2975. doi: 10.1016/j.jtha.2024.07.013. Epub 2024 Aug 2. J Thromb Haemost. 2024. PMID: 39097232 Review.

6

Molecular biology and targeted therapies for urothelial carcinoma.

Seront E, Machiels JP. Seront E, et al. Cancer Treat Rev. 2015 Apr;41(4):341-53. doi: 10.1016/j.ctrv.2015.03.004. Epub 2015 Mar 24. Cancer Treat Rev. 2015. PMID: 25828962 Review.

7

Immune checkpoint inhibitors as a real hope in advanced urothelial carcinoma.

Seront E, Catala G, Dermine A, Lejeune S, Rysselinck S. Seront E, et al. Future Sci OA. 2018 Oct 4;4(10):FSO341. doi: 10.4155/fsoa-2018-0033. eCollection 2018 Dec. Future Sci OA. 2018. PMID: 30457576 Free PMC article. Review.

8

Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab.

Pierrard J, Petit B, Lejeune S, Seront E. Pierrard J, et al. Among authors: seront e. BMJ Case Rep. 2019 Aug 21;12(8):e230848. doi: 10.1136/bcr-2019-230848. BMJ Case Rep. 2019. PMID: 31439558 Free PMC article.

9

Impact of the gut microbiome on immune checkpoint inhibitor efficacy-a systematic review.

Pierrard J, Seront E. Pierrard J, et al. Among authors: seront e. Curr Oncol. 2019 Dec;26(6):395-403. doi: 10.3747/co.26.5177. Epub 2019 Dec 1. Curr Oncol. 2019. PMID: 31896938 Free PMC article.

10

c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis.

Van den Bossche V, Jadot G, Grisay G, Pierrard J, Honoré N, Petit B, Augusto D, Sauvage S, Laes JF, Seront E. Van den Bossche V, et al. Among authors: seront e. Target Oncol. 2020 Feb;15(1):139-146. doi: 10.1007/s11523-020-00704-2. Target Oncol. 2020. PMID: 32020516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters